NEW YORK (360Dx) – Alere diabetes subsidiary Arriva Medical said yesterday that a US District Court has denied a motion to dismiss its lawsuit against the Centers for Medicare and Medicaid Services (CMS). The court, however, also denied Arriva's request for interim relief in the case, which centers around revocation of the company's Medicare billing privileges.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.